Maryland Stem Cell Research Fund - Discovery Program

The Maryland Stem Cell Research Fund Discovery Program is a state-funded initiative administered to advance the development of human stem cell-based technologies and therapies. The program is designed to support innovative research that contributes to the understanding, prevention, diagnosis, and treatment of human diseases, injuries, and conditions. The funder prioritizes scientific advancement within Maryland’s biotechnology ecosystem and encourages research that may lead to improved patient outcomes and commercialization opportunities. The primary objective of the Discovery Program is to fund early-stage, high-impact research projects that explore new hypotheses, mechanisms, or methodologies in the field of human stem cell science. The program supports both basic and translational research, provided that the work directly involves human stem cells or related technologies such as stem cell derivatives and enabling tools. While preliminary or proof-of-concept data is encouraged, it is not required, allowing researchers to pursue novel and potentially transformative ideas. Funding under this program provides up to 350000 dollars per award for a maximum project duration of two years. These funds may be used for a range of direct costs including salaries and fringe benefits for key personnel, equipment, supplies, consultant services, collaboration expenses, and limited travel costs. Indirect costs are capped at 15 percent of direct costs. However, certain restrictions apply, including a prohibition on using funds to support personnel located outside of Maryland, although non-personnel expenses may occur outside the state. International travel is not permitted, and domestic travel is limited to a maximum of 5000 dollars. Eligibility is restricted to academic scientists employed by Maryland-based public or private nonprofit research organizations such as universities, colleges, research institutes, and medical centers. Federal laboratories are not eligible to apply as primary applicants, although collaboration with such entities is permitted under specific conditions. All funded research must be conducted within Maryland, and awardees must obtain appropriate regulatory approvals, including IRB, IACUC, and SCRO approvals where applicable, prior to receiving funds. The application process requires submission through the MSCRF online portal and includes multiple structured components. Applicants must complete web-based questions covering project details, funding requests, and ethical considerations, along with uploading required documents such as a research plan, project summary, data sharing strategy, biosketches, budget justification, and supporting materials. Strict formatting and page limits apply, and non-compliant applications will be rejected without review. Applications undergo a multi-stage review process beginning with an eligibility and compliance review followed by scientific peer review. Proposals are evaluated based on criteria such as scientific rationale, innovation, investigator qualifications, research approach, resource environment, translational potential, and bioethics considerations. Final funding decisions are made by the Commission based on reviewer rankings and program priorities. The funding cycle outlined in the RFA indicates an application deadline of January 12, 2026, with peer review occurring in March and award announcements expected in May. Awardees are required to comply with reporting obligations including mid-term and final reports, as well as participation in program meetings and symposium presentations. The program is recurring and aligns with periodic funding cycles released by the Maryland Stem Cell Research Fund.

Emphasize innovation and strong scientific rationale; clearly demonstrate translational potential and impact on human disease; ensure strict compliance with formatting and page limits; provide thorough bioethics justification and regulatory readiness